Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Articles and issues > Previous issues
16 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 49(1); January 2015
Prev issue Next issue
Letter to the editor
TdT+ T-Lymphoblastic Proliferation in Castleman Disease
Chang Gok Woo, Jooryung Huh
J Pathol Transl Med. 2015;49(1):1-4.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.11.17
  • 9,610 View
  • 114 Download
  • 9 Citations
PDF

Citations

Citations to this article as recorded by  
  • Indolent T-lymphoblastic proliferation: a report of three cases
    Zheng Yuanyuan, Xie Jianlan, Zhang Yanlin, Zhou Xiaoge
    Virchows Archiv.2022; 480(5): 1121.     CrossRef
  • Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease
    Nabin Raj Karki, Ahmed Samire Arfa, Natasha Savage, Abdullah Kutlar
    Acta Haematologica.2022; 145(2): 214.     CrossRef
  • Indolent T‐lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases
    Arzu Saglam, Kunwar Singh, Sumanth Gollapudi, Jyoti Kumar, Nivaz Brar, Alexandra Butzmann, Roger Warnke, Robert S. Ohgami
    International Journal of Laboratory Hematology.2022; 44(4): 700.     CrossRef
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
    Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K. C. Chan, Wah Cheuk, Wee-Joo Chng,
    Leukemia.2022; 36(7): 1720.     CrossRef
  • T-lymphoblastic leukemia/lymphoma with interfollicular growth pattern and Castleman-like morphologic features
    Weijie Li, Alexander Kats, Linda D. Cooley, Midhat S. Farooqi, Keith August
    Journal of Hematopathology.2021; 14(2): 163.     CrossRef
  • Maladie de Castleman localisée avec prolifération lymphoblastique T indolente
    Bertrand Chauveau, François Le Loarer, Julia Bacci, François Baylac, Pierre Dubus, Catherine Ling, Marie Parrens
    Annales de Pathologie.2019; 39(1): 29.     CrossRef
  • Sirolimus for the Treatment of Airway Obstruction due to Indolent T-Lymphoblastic Proliferation
    Eric Moughames, Ana P. Kiess, Lee M. Akst, Antoine Azar
    Case Reports in Immunology.2019; 2019: 1.     CrossRef
  • Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review
    Hajime Yasuda, Miyuki Tsutsui, Yasunori Ota, Masaru Tanaka, Norio Komatsu
    Histopathology.2018; 72(5): 862.     CrossRef
  • Indolent T-lymphoblastic proliferation: a name with specific meaning—reply
    Bharat N. Nathwani, Rina Kansal, Xanthi Yiakoumis, Gerassimos A. Pangalis
    Human Pathology.2015; 46(11): 1786.     CrossRef
Reviews
Molecular Imaging in the Era of Personalized Medicine
Kyung-Ho Jung, Kyung-Han Lee
J Pathol Transl Med. 2015;49(1):5-12.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.24
  • 10,629 View
  • 182 Download
  • 21 Citations
AbstractAbstract PDF
Clinical imaging creates visual representations of the body interior for disease assessment. The role of clinical imaging significantly overlaps with that of pathology, and diagnostic workflows largely depend on both fields. The field of clinical imaging is presently undergoing a radical change through the emergence of a new field called molecular imaging. This new technology, which lies at the intersection between imaging and molecular biology, enables noninvasive visualization of biochemical processes at the molecular level within living bodies. Molecular imaging differs from traditional anatomical imaging in that biomarkers known as imaging probes are used to visualize target molecules-of-interest. This ability opens up exciting new possibilities for applications in oncologic, neurological and cardiovascular diseases. Molecular imaging is expected to make major contributions to personalized medicine by allowing earlier diagnosis and predicting treatment response. The technique is also making a huge impact on pharmaceutical development by optimizing preclinical and clinical tests for new drug candidates. This review will describe the basic principles of molecular imaging and will briefly touch on three examples (from an immense list of new techniques) that may contribute to personalized medicine: receptor imaging, angiogenesis imaging, and apoptosis imaging.

Citations

Citations to this article as recorded by  
  • Quantum Biotechnology
    Nicolas P. Mauranyapin, Alex Terrasson, Warwick P. Bowen
    Advanced Quantum Technologies.2022; 5(9): 2100139.     CrossRef
  • Preparation Fe3O4@chitosan-graphene quantum dots nanocomposites for fluorescence and magnetic resonance imaging
    Kai Wang, Xiaoguang Xu, Yan Li, Mayifei Rong, Lifeng Wang, Liying Lu, Jian Wang, Fengwen Zhao, Bowen Sun, Yong Jiang
    Chemical Physics Letters.2021; 783: 139060.     CrossRef
  • Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease
    Teresa Infante, Luca Del Viscovo, Maria Luisa De Rimini, Sergio Padula, Pio Caso, Claudio Napoli
    Journal of Atherosclerosis and Thrombosis.2020; 27(4): 279.     CrossRef
  • Nanodrug Delivery Systems for the Treatment of Ovarian Cancer
    Jonathan M. Pantshwa, Pierre P. D. Kondiah, Yahya E. Choonara, Thashree Marimuthu, Viness Pillay
    Cancers.2020; 12(1): 213.     CrossRef
  • Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
    V. M. Baart, R. D. Houvast, L. F. de Geus-Oei, P. H. A. Quax, P. J. K. Kuppen, A. L. Vahrmeijer, C. F. M. Sier
    EJNMMI Research.2020;[Epub]     CrossRef
  • In vivo SPECT imaging of an 131I-labeled PM 2.5 mimic substitute
    Dong-Hui Pan, Jie Sheng, Xin-Yu Wang, Qian-Huan Huang, Jun-Jie Yan, Li-Zhen Wang, Run-Ling Yang, Dong-Jian Shi, Yu-Ping Xu, Ming-Qing Chen
    Nuclear Science and Techniques.2020;[Epub]     CrossRef
  • Optofluidics in bio-imaging applications
    Sihui Chen, Rui Hao, Yi Zhang, Hui Yang
    Photonics Research.2019; 7(5): 532.     CrossRef
  • Nitrogen-vacancy centers in diamond for nanoscale magnetic resonance imaging applications
    Alberto Boretti, Lorenzo Rosa, Jonathan Blackledge, Stefania Castelletto
    Beilstein Journal of Nanotechnology.2019; 10: 2128.     CrossRef
  • Online molecular image repository and analysis system: A multicenter collaborative open-source infrastructure for molecular imaging research and application
    Mahabubur Rahman, Hiroshi Watabe
    Computers in Biology and Medicine.2018; 96: 233.     CrossRef
  • Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling
    Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, Elisabeth Jäckel, David Bauer, Martin Lohse, Alan Wong, Johanna Pufe, Friedrich-Alexander Ludwig, Steffen Fischer, Sandra Hauser, Dieter Greif, M. Teresa Pisabarro, Jens Pietzsch, Markus Pietsch, Reik Lö
    Journal of Medicinal Chemistry.2018; 61(10): 4528.     CrossRef
  • Genomic Interventions in Medicine
    Oluwadurotimi S Aworunse, Oluwatomiwa Adeniji, Olusola L Oyesola, Itunuoluwa Isewon, Jelili Oyelade, Olawole O Obembe
    Bioinformatics and Biology Insights.2018; 12: 117793221881610.     CrossRef
  • Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI
    Ryan L. Brunsing, Natalie M. Schenker-Ahmed, Nathan S. White, J. Kellogg Parsons, Christopher Kane, Joshua Kuperman, Hauke Bartsch, Andrew Karim Kader, Rebecca Rakow-Penner, Tyler M. Seibert, Daniel Margolis, Steven S. Raman, Carrie R. McDonald, Nikdokht
    Journal of Magnetic Resonance Imaging.2017; 45(2): 323.     CrossRef
  • Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium
    Orazio Schillaci, Nicoletta Urbano
    European Journal of Nuclear Medicine and Molecular Imaging.2017; 44(4): 563.     CrossRef
  • Nano-Magnetic Resonance Imaging (Nano-MRI) Gives Personalized Medicine a New Perspective
    Lorenzo Rosa, Jonathan Blackledge, Albert Boretti
    Biomedicines.2017; 5(4): 7.     CrossRef
  • Optical nanoprobes for biomedical applications: shining a light on upconverting and near-infrared emitting nanoparticles for imaging, thermal sensing, and photodynamic therapy
    E. Hemmer, P. Acosta-Mora, J. Méndez-Ramos, S. Fischer
    Journal of Materials Chemistry B.2017; 5(23): 4365.     CrossRef
  • Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma
    Senthilkumar Kalimuthu, Ju Hye Jeong, Ji Min Oh, Byeong-Cheol Ahn
    International Journal of Molecular Sciences.2017; 18(8): 1639.     CrossRef
  • Chemistry and engineering of cyclodextrins for molecular imaging
    Wing-Fu Lai, Andrey L. Rogach, Wing-Tak Wong
    Chemical Society Reviews.2017; 46(20): 6379.     CrossRef
  • Prototypes of Lanthanide(III) Agents Responsive to Enzymatic Activities in Three Complementary Imaging Modalities: Visible/Near-Infrared Luminescence, PARACEST-, and T1-MRI
    Jiefang He, Célia S. Bonnet, Svetlana V. Eliseeva, Sara Lacerda, Thomas Chauvin, Pascal Retailleau, Frederic Szeremeta, Bernard Badet, Stéphane Petoud, Éva Tóth, Philippe Durand
    Journal of the American Chemical Society.2016; 138(9): 2913.     CrossRef
  • Nanoparticles in practice for molecular-imaging applications: An overview
    Parasuraman Padmanabhan, Ajay Kumar, Sundramurthy Kumar, Ravi Kumar Chaudhary, Balázs Gulyás
    Acta Biomaterialia.2016; 41: 1.     CrossRef
  • A new neuroinformatics approach to personalized medicine in neurology: The Virtual Brain
    Maria I. Falcon, Viktor Jirsa, Ana Solodkin
    Current Opinion in Neurology.2016; 29(4): 429.     CrossRef
  • Targeted multimodal nano-reporters for pre-procedural MRI and intra-operative image-guidance
    Joonseok Lee, Andrew C. Gordon, Hacksung Kim, Wooram Park, Soojeong Cho, Byeongdu Lee, Andrew C. Larson, Elena A. Rozhkova, Dong-Hyun Kim
    Biomaterials.2016; 109: 69.     CrossRef
Genomic Landscapes of Pancreatic Neoplasia
Laura D. Wood, Ralph H. Hruban
J Pathol Transl Med. 2015;49(1):13-22.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.12.26
  • 10,796 View
  • 105 Download
  • 13 Citations
AbstractAbstract PDF
Pancreatic cancer is a deadly disease with a dismal prognosis. However, recent advances in sequencing and bioinformatic technology have led to the systematic characterization of the genomes of all major tumor types in the pancreas. This characterization has revealed the unique genomic landscape of each tumor type. This knowledge will pave the way for improved diagnostic and therapeutic approaches to pancreatic tumors that take advantage of the genetic alterations in these neoplasms.

Citations

Citations to this article as recorded by  
  • Pancreatoblastoma with a novel fusion gene of IQSEC1‐RAF1
    Hironori Goto, Yuhki Koga, Kenichi Kohashi, Hiroaki Ono, Junkichi Takemoto, Toshiharu Matsuura, Tatsuro Tajiri, Kenji Ihara, Yoshinao Oda, Shouichi Ohga
    Pediatric Blood & Cancer.2022;[Epub]     CrossRef
  • Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma
    Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun
    European Journal of Nuclear Medicine and Molecular Imaging.2020; 47(9): 2113.     CrossRef
  • NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS
    Mitali Chattopadhyay, Ravinder Kodela, Gabriela Santiago, Thuy Tien C. Le, Niharika Nath, Khosrow Kashfi
    Biochemical Pharmacology.2020; 176: 113857.     CrossRef
  • Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
    Friederike Inga Nollmann, Dietrich Alexander Ruess
    Biomedicines.2020; 8(8): 281.     CrossRef
  • Ancillary Techniques in Cytologic Specimens Obtained from Solid Lesions of the Pancreas: A Review
    Jonas J. Heymann, Momin T. Siddiqui
    Acta Cytologica.2020; 64(1-2): 103.     CrossRef
  • DNA polymerase η mutational signatures are found in a variety of different types of cancer
    Igor B. Rogozin, Alexander Goncearenco, Artem G. Lada, Subhajyoti De, Vyacheslav Yurchenko, German Nudelman, Anna R. Panchenko, David N. Cooper, Youri I. Pavlov
    Cell Cycle.2018; 17(3): 348.     CrossRef
  • Genetics of Pancreatic Neoplasms and Role of Screening
    Venkata S. Katabathina, Omid Y. Rikhtehgar, Anil K. Dasyam, Rohan Manickam, Srinivasa R. Prasad
    Magnetic Resonance Imaging Clinics of North America.2018; 26(3): 375.     CrossRef
  • Team work and cytopathology molecular diagnosis of solid pancreatic lesions
    Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario Bia
    Digestive Endoscopy.2017; 29(6): 657.     CrossRef
  • Mutational signatures and mutable motifs in cancer genomes
    Igor B. Rogozin, Youri I. Pavlov, Alexander Goncearenco, Subhajyoti De, Artem G. Lada, Eugenia Poliakov, Anna R. Panchenko, David N. Cooper
    Briefings in Bioinformatics.2017;[Epub]     CrossRef
  • The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA
    Ferga C. Gleeson, Michael J. Levy
    Gastrointestinal Endoscopy.2016; 83(1): 149.     CrossRef
  • MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors
    Rui Gradiz, Henriqueta C. Silva, Lina Carvalho, Maria Filomena Botelho, Anabela Mota-Pinto
    Scientific Reports.2016;[Epub]     CrossRef
  • p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells
    Stephanie Azzopardi, Sharon Pang, David S. Klimstra, Yi-Chieh Nancy Du
    Neoplasia.2016; 18(10): 610.     CrossRef
  • MicroRNA-506 participates in pancreatic cancer pathogenesis by targeting PIM3
    JUNDONG DU, XI ZHENG, SHOUWANG CAI, ZIMAN ZHU, JINGWANG TAN, BIN HU, ZHIQIANG HUANG, HUABO JIAO
    Molecular Medicine Reports.2015; 12(4): 5121.     CrossRef
Original Articles
PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors
Yooju Shin, Jiyeon Hyeon, Boram Lee, Sang Yun Ha, Min Eui Hong, In Gu Do, Kyoung-Mee Kim
J Pathol Transl Med. 2015;49(1):23-29.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.08
  • 7,939 View
  • 67 Download
  • 7 Citations
AbstractAbstract PDF
Background
Counting mitoses is subjective and time-consuming. The adjunctive diagnostic utility of a recently reported mitotic marker, phosphohistone H3 (PHH3), was investigated in gastrointestinal stromal tumors (GISTs). Methods: We reviewed 77 GISTs for several proliferative indices. These included the mitotic count per 50 high power fields (HPFs), the immunohistochemical Ki- 67 labeling index and the immunohistochemical PHH3 mitotic index (MI). For comparison, Spearman’s rank correlation and interclass correlation coefficient were used. Results: Mitotic counts ranged from 0–138 (mean, 7.57±2.34) and the PHH3 MI ranged from 0–126 per 50 HPFs (mean, 9.61±2.27). We found a positive correlation between mitotic counts and PHH3 MI (r=0.810, p<.001). The inter-observer correlation coefficient for three participants was 0.975 for mitotic counts and 0.940 for the PHH3 MI. When using the PHH3 MI instead of mitotic counts in the Armed Forces Institute of Pathology (AFIP) stratification criteria, 10 cases were reclassified. In one patient with a mitotic count of 2 and a PHH3 MI of 6 per 50 HPFs, distant metastasis occurred. Conclusions: In GISTs, the PHH3 MI correlated adequately with mitotic counts and can be used as a useful adjunctive to count mitotic figures efficiently.

Citations

Citations to this article as recorded by  
  • Loss of Slfn3 induces a sex-dependent repair vulnerability after 50% bowel resection
    Emilie E. Vomhof-DeKrey, Jack T. Lansing, Diane C. Darland, Josey Umthun, Allie D. Stover, Christopher Brown, Marc D. Basson
    American Journal of Physiology-Gastrointestinal and Liver Physiology.2021; 320(2): G136.     CrossRef
  • Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies
    Napaporn Puripat, Kongsak Loharamtaweethong
    Virchows Archiv.2019; 474(1): 87.     CrossRef
  • Gastrointestinal Stromal Tumors Risk Stratification Utilizing Phospho-Histone H3 Evaluated by Manual Counting and Computer-Assisted Image Analysis
    Cao Jin, Yan Huang, Mansoor Nasim, Yihe Yang, Lili Lee
    International Journal of Surgical Pathology.2019; 27(7): 706.     CrossRef
  • The utility of phosphohistone H3 in early prediction of benign and borderline phyllodes tumor recurrence
    AymenM El-Saka, MohamedA Mlees, YomnaA Zamzam
    Egyptian Journal of Pathology.2019; 39(2): 402.     CrossRef
  • Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors
    Min Jeong Kim, Mi Jung Kwon, Ho Suk Kang, Kyung Chan Choi, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Hyoung-Chul Park
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Tumor Digital Masking Allows Precise Patient Triaging: A Study Based on Ki-67 Scoring in Gastrointestinal Stromal Tumors
    Piotr Lewitowicz, Jaroslaw Matykiewicz, Magdalena Chrapek, Dorota Koziel, Agata Horecka-Lewitowicz, Martyna Gluszek-Osuch, Iwona Wawrzycka, Stanisław Gluszek
    Scanning.2018; 2018: 1.     CrossRef
  • The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study
    Kin-Long Chow, Ka-Yu Tse, Ching-Lung Cheung, Ka-Wing Wong, Annie N Y Cheung, Richard W C Wong, Alice N H Chan, Nancy W F Yuen, Hextan Y S Ngan, Philip P C Ip
    Histopathology.2017; 70(5): 746.     CrossRef
Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors
Eun-Mi Son, Joo Young Kim, Soyeon An, Ki-Byung Song, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
J Pathol Transl Med. 2015;49(1):30-36.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.23
  • 9,615 View
  • 80 Download
  • 17 Citations
AbstractAbstract PDF
Background
Pancreatic neuroendocrine tumors (PanNETs) are malignant endocrine neoplasms that present diverse clinical behaviors. Therefore, identification of biomarkers of PanNETs is important for stratification of the prognosis of PanNET patients. Recently, cytokeratin 19 (CK19) and KIT expression were reported to have prognostic significance in PanNET patients. Methods: To identify their prognostic significance, CK19 and KIT protein expression were assessed in 182 surgically resected PanNETs and compared with clinicopathologic factors. Results: Of 182 PanNETs cases, CK19 and KIT expression was noted in 97 (53.3%) and 16 (8.8%) cases, respectively. PanNET patients with CK19 expression had larger tumors (p=.006), higher World Health Organization (WHO) grade (p=.002) and pT classification (p<.001), increased distant metastasis (p=.004), and lymphovascular (p=.012) and perineural (p=.019) invasion. Similarly, those with KIT expression had larger tumors (p=.030), higher WHO grade (p=.001), advanced pT classification (p<.001), distant metastasis (p=.001), and lymphovascular invasion (p=.014). The 5-year survival rate for PanNET patients with KIT expression was significantly lower (62%) than that of patients without KIT expression (77%, p=.011), as determined by univariate but not by multivariate analyses. Conclusions: CK19 and KIT expression correlate with higher metastatic potential and advanced disease stage, and KIT expression is associated with worse survival in PanNET patients.

Citations

Citations to this article as recorded by  
  • Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor
    Bokyung Ahn, Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2023; 147(1): 100.     CrossRef
  • Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
    Chengcao Sun, Youqiong Ye, Zhi Tan, Yuan Liu, Yajuan Li, Wei Hu, Ke Liang, Sergey D. Egranov, Lisa Angela Huang, Zhao Zhang, Yaohua Zhang, Jun Yao, Tina K. Nguyen, Zilong Zhao, Andrew Wu, Jeffrey R. Marks, Abigail S. Caudle, Aysegul A. Sahin, Jianjun Gao,
    Science Advances.2023;[Epub]     CrossRef
  • Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors
    Anne Menz, Rifka Bauer, Martina Kluth, Clara Marie von Bargen, Natalia Gorbokon, Florian Viehweger, Maximilian Lennartz, Cosima Völkl, Christoph Fraune, Ria Uhlig, Claudia Hube-Magg, Noémi De Wispelaere, Sarah Minner, Guido Sauter, Simon Kind, Ronald Simo
    Human Pathology.2021; 115: 19.     CrossRef
  • The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities
    Kate Young, Naureen Starling, Anguraj Sadanandam
    Seminars in Cancer Biology.2020; 61: 132.     CrossRef
  • Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours
    Joo Young Kim, Jacqueline A. Brosnan-Cashman, Jiyoon Kim, Soyeon An, Kyoung-Bun Lee, Haeryoung Kim, Do Youn Park, Kee-Taek Jang, Young-Ha Oh, Ralph H. Hruban, Christopher M. Heaphy, Seung-Mo Hong
    Pathology.2020; 52(3): 336.     CrossRef
  • Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification
    Yue Xue, Michelle D. Reid, Burcin Pehlivanoglu, Rebecca C. Obeng, Hongmei Jiang, Bahar Memis, Shu K. Lui, Juan Sarmiento, David Kooby, Shishir K. Maithel, Bassel El-Rayes, Olca Basturk, Volkan Adsay
    Endocrine Pathology.2020; 31(3): 239.     CrossRef
  • Histological grades and prognostic markers of well-differentiated pancreatic neuroendocrine tumor (WDPNET)
    Yongchao Li, Daniel Rowan, Claire P. Williamson, Meiyun Fan, Ali G. Saad, Lizhi Zhang
    Journal of Pancreatology.2020; 3(4): 188.     CrossRef
  • Clinical and histopathologic prognostic implications of the expression of cytokeratins 8, 10, 13, 14, 16, 18 and 19 in oral and oropharyngeal squamous cell carcinoma
    Rima A. Safadi, Niveen I. Abdullah, Rolla F. Alaaraj, Dima H. Bader, Darshan D. Divakar, Abed A. Hamasha, Maher A. Sughayer
    Archives of Oral Biology.2019; 99: 1.     CrossRef
  • Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
    Lingaku Lee, Tetsuhide Ito, Robert T Jensen
    Expert Review of Anticancer Therapy.2019; 19(12): 1029.     CrossRef
  • Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival
    Joo Young Kim, Sang Hwa Lee, Soyeon An, Sung Joo Kim, You-Na Sung, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Seung-Mo Hong
    Virchows Archiv.2018; 472(5): 739.     CrossRef
  • CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses
    Yasuhiro Sakai, Seung-Mo Hong, Soyeon An, Joo Young Kim, Denis Corbeil, Jana Karbanová, Kyoko Otani, Kohei Fujikura, Ki-Byung Song, Song Cheol Kim, Masayuki Akita, Yoshihide Nanno, Hirochika Toyama, Takumi Fukumoto, Yonson Ku, Takanori Hirose, Tomoo Itoh,
    Human Pathology.2017; 61: 148.     CrossRef
  • Prognostic and predictive biomarkers in neuroendocrine tumours
    David L. Chan, Stephen J. Clarke, Connie I. Diakos, Paul J. Roach, Dale L. Bailey, Simron Singh, Nick Pavlakis
    Critical Reviews in Oncology/Hematology.2017; 113: 268.     CrossRef
  • Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients
    Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong
    Journal of Pathology and Translational Medicine.2017; 51(4): 388.     CrossRef
  • Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis
    Dong Cen, Jiang Chen, Zheyong Li, Jie Zhao, Xiujun Cai, Aamir Ahmad
    PLOS ONE.2017; 12(11): e0187588.     CrossRef
  • A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases
    Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen
    International Journal of Surgery.2016; 29: 108.     CrossRef
  • Correlating and Combining Genomic and Proteomic Assessment withIn VivoMolecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
    Bhakti Basu, Sandip Basu
    Cancer Biotherapy and Radiopharmaceuticals.2016; 31(3): 75.     CrossRef
  • Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
    Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.     CrossRef
Transglutaminase 2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma
Min Jee Park, Hae Woon Baek, Ye-Young Rhee, Cheol Lee, Jeong Whan Park, Hwal Woong Kim, Kyung Chul Moon
J Pathol Transl Med. 2015;49(1):37-43.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.25
  • 7,938 View
  • 63 Download
  • 13 Citations
AbstractAbstract PDF
Background
A few recent studies have demonstrated a possible role of transglutaminase 2 (TG2) in tumorigenesis or progression of renal cell carcinoma (RCC). The aim of this study was to examine TG2 expression and its clinicopathologic significance in a large number of human clear cell RCCs (CCRCCs). Methods: We analyzed 638 CCRCC patients who underwent partial or radical nephrectomy between 1995 and 2005. The expression of TG2 was determined by immunohistochemistry and categorized into four groups, according to staining intensity: negative (0), mild (1+), moderate (2+), and strong (3+). Results: TG2 staining intensity was negative in 8.5% of CCRCC (n=54), 1+ in 32.6% (n=208), 2+ in 50.5% (n=322), and 3+ in 8.5% (n=54). Strong TG2 expression was correlated with high Fuhrman nuclear grade (p=.011), high T category (p=.049), metastasis (p=.043) and male sex (p<.001) but not with N category.The survival analysis showed a significant association between strong TG2 expression and worse overall and cancer-specific survival (p=.027 and p=.010, respectively). On multivariate analysis, strong TG2 expression was a marginally significant prognostic indicator for Fuhrman nuclear grade and TNM staging (p=.054). Conclusions: Our study is the first to demonstrate the clinicopathologic significance of TG2 expression in a large number of human CCRCC samples. Strong TG2 expression was associated with high nuclear grade and poor prognosis.

Citations

Citations to this article as recorded by  
  • Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates
    Sandra Hauser, Paul Sommerfeld, Johanna Wodtke, Christoph Hauser, Paul Schlitterlau, Jens Pietzsch, Reik Löser, Markus Pietsch, Robert Wodtke
    International Journal of Molecular Sciences.2022; 23(9): 4475.     CrossRef
  • The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment
    Robert Tempest, Sonia Guarnerio, Rawan Maani, Jamie Cooper, Nicholas Peake
    Cancers.2021; 13(11): 2788.     CrossRef
  • A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
    Soo-Youl Kim, Jeffrey W. Keillor
    International Journal of Molecular Sciences.2020; 21(7): 2493.     CrossRef
  • Evaluation of nuclear NF-κB, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors
    Alan A. Azambuja, Paula Engroff, Bruna T. Silva, Roberta C. S. Zorzetti, Fernanda B. Morrone
    International braz j urol.2020; 46(3): 353.     CrossRef
  • Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma
    Seon-Hyeong Lee, Joon Hee Kang, Ji Sun Ha, Jae-Seon Lee, Su-Jin Oh, Hyun-Jung Choi, Jaewhan Song, Soo-Youl Kim
    International Journal of Molecular Sciences.2020; 21(14): 5042.     CrossRef
  • Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression
    Burge Ulukan, Ajna Bihorac, Tarik Sipahioglu, Robert Kiraly, Laszlo Fesus, Dilek Telci
    ACS Omega.2020; 5(43): 28273.     CrossRef
  • Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma
    Ayca Ece Nezir, Burge Ulukan, Dilek Telci
    Medical Sciences.2019; 7(2): 24.     CrossRef
  • Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
    Richard L. Eckert
    Molecular Carcinogenesis.2019; 58(6): 837.     CrossRef
  • Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus
    Nayeon Kim, Joon Hee Kang, Won-Kyu Lee, Seul-Gi Kim, Jae-Seon Lee, Seon-Hyeong Lee, Jong Bae Park, Kyung-Hee Kim, Young-Dae Gong, Kwang Yeon Hwang, Soo-Youl Kim
    Amino Acids.2018; 50(11): 1583.     CrossRef
  • Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
    Seon-Hyeong Lee, Won-Kyu Lee, Nayeon Kim, Joon Kang, Kyung-Hee Kim, Seul-Gi Kim, Jae-Seon Lee, Soohyun Lee, Jongkook Lee, Jungnam Joo, Woo Kwon, Sun Rha, Soo-Youl Kim
    Cancers.2018; 10(11): 455.     CrossRef
  • Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma
    Yesim Bagatur, Ayca Zeynep Ilter Akulke, Ajna Bihorac, Merve Erdem, Dilek Telci
    Cell Adhesion & Migration.2017; : 1.     CrossRef
  • Characterization of clear cell renal cell carcinoma by gene expression profiling
    Bryan J. Thibodeau, Matthew Fulton, Laura E. Fortier, Timothy J. Geddes, Barbara L. Pruetz, Samreen Ahmed, Amy Banes-Berceli, Ping L. Zhang, George D. Wilson, Jason Hafron
    Urologic Oncology: Seminars and Original Investigations.2016; 34(4): 168.e1.     CrossRef
  • Prognostic role of tissue transglutaminase 2 in colon carcinoma
    María Jesús Fernández-Aceñero, Sofía Torres, Irene Garcia-Palmero, Cristina Díaz del Arco, J. Ignacio Casal
    Virchows Archiv.2016; 469(6): 611.     CrossRef
Expression of c-MET in Invasive Meningioma
Sumi Yun, Jae Moon Koh, Kyu Sang Lee, An Na Seo, Kyung Han Nam, Gheeyoung Choe
J Pathol Transl Med. 2015;49(1):44-51.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.13
  • 8,191 View
  • 66 Download
  • 18 Citations
AbstractAbstract PDF
Background
Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have been reported to be involved in cancer invasion. Methods: We examined the immunohistochemical expression of c-MET and HGF in 100 cases of patients with meningiomas who have undergone complete tumor removal. Results: c-MET-High and HGFHigh were found in 17% and 13% of meningiomas, respectively. Brain invasion was observed in 17.6% of c-MET-High meningiomas, but in only 2.4% of c-MET-Low meningiomas (p=.033). Bone/ soft tissue invasion was observed in 23.5% of c-MET-High meningiomas and in 9.6% of c-MET-Low meningiomas (p=.119). HGF-High did not show statistical association with brain invasion or bone/ soft tissue invasion. c-MET-High demonstrated shorter recurrence-free survival (RFS, 93.5±8.2 months vs 96.1±1.9 months); however, this difference was not statistically significant (p=.139). There was no association of HGF-High with RFS. Conclusions: This study demonstrates that c- MET-High is associated with brain invasion of meningiomas, and that c-MET expression may be a useful predictive marker for meningioma recurrence. Patients with invasive meningiomas with high expressions of c-MET may be good candidates for targeted therapy using c-MET inhibitors.

Citations

Citations to this article as recorded by  
  • The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
    Jun Jiang, Juan Yu, Xiajing Liu, Kan Deng, Kaichao Zhuang, Fan Lin, Liangping Luo
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review
    Ataollah Shahbandi, Darsh S. Shah, Caroline C. Hadley, Akash J. Patel
    Cancers.2023; 15(2): 483.     CrossRef
  • Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases
    Thiébaud Picart, Chloé Dumot, Jacques Guyotat, Vladislav Pavlov, Nathalie Streichenberger, Alexandre Vasiljevic, Tanguy Fenouil, Anne Durand, Emmanuel Jouanneau, François Ducray, Timothée Jacquesson, Moncef Berhouma, David Meyronet
    Neurosurgical Review.2022; 45(4): 2797.     CrossRef
  • Nomogram based on MRI can preoperatively predict brain invasion in meningioma
    Jing Zhang, Yuntai Cao, Guojin Zhang, Zhiyong Zhao, Jianqing Sun, Wenyi Li, Jialiang Ren, Tao Han, Junlin Zhou, Kuntao Chen
    Neurosurgical Review.2022; 45(6): 3729.     CrossRef
  • Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma
    Farhad Mashayekhi, Soheila Talesh Sasani, Alia Saberi, Zivar Salehi
    Journal of Clinical Neuroscience.2021; 93: 1.     CrossRef
  • Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options
    Chaoying Qin, Meng Huang, Yimin Pan, Yuzhe Li, Wenyong Long, Qing Liu
    Brain Tumor Pathology.2021; 38(3): 156.     CrossRef
  • YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas
    Kathleen M. Schieffer, Vibhuti Agarwal, Stephanie LaHaye, Katherine E. Miller, Daniel C. Koboldt, Tara Lichtenberg, Kristen Leraas, Patrick Brennan, Benjamin J. Kelly, Erin Crist, Jerome Rusin, Jonathan L. Finlay, Diana S. Osorio, Eric A. Sribnick, Jeffre
    American Journal of Surgical Pathology.2021; 45(3): 329.     CrossRef
  • Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
    Rupesh Kotecha, Raees Tonse, Haley Appel, Yazmin Odia, Ritesh R. Kotecha, Guilherme Rabinowits, Minesh P. Mehta
    Current Oncology.2021; 28(2): 1537.     CrossRef
  • Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis
    Satoshi Nakasu, Yoko Nakasu
    Brain Tumor Pathology.2021; 38(2): 81.     CrossRef
  • Curcumin Inhibits HGF-Induced EMT by Regulating c-MET-Dependent PI3K/Akt/mTOR Signaling Pathways in Meningioma
    Xiaodong Chen, Fen Tian, Peng Lun, Yugong Feng, Ho Lin
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • Letter to the Editor. Preoperative seizures as predictive sign of brain invasion by meningioma
    Mikhail F. Chernov
    Journal of Neurosurgery.2019; 130(3): 1030.     CrossRef
  • Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection
    Yoon Ah Cho, Ji Myung Chung, Hyunmi Ryu, Eun Kyung Kim, Byoung Chul Cho, Sun Och Yoon
    Cancer Research and Treatment.2019; 51(3): 1052.     CrossRef
  • Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging
    Alborz Adeli, Katharina Hess, Christian Mawrin, Eileen Maria Susanne Streckert, Walter Stummer, Werner Paulus, André Kemmling, Markus Holling, Walter Heindel, Rene Schmidt, Dorothee Cäcilia Spille, Peter B. Sporns, Benjamin Brokinkel
    Oncotarget.2018; 9(89): 35974.     CrossRef
  • Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature
    A. Paix, W. Waissi, D. Antoni, R. Adeduntan, G. Noël
    Cancer/Radiothérapie.2017; 21(1): 55.     CrossRef
  • Letter: Brain Invasion in Meningiomas—Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression
    Katharina Heß, Dorothee Cäcilia Spille, Andrea Wagner, Walter Stummer, Werner Paulus, Benjamin Brokinkel
    Neurosurgery.2017; 81(2): E25.     CrossRef
  • Brain invasion in meningiomas—clinical considerations and impact of neuropathological evaluation: a systematic review
    Benjamin Brokinkel, Katharina Hess, Christian Mawrin
    Neuro-Oncology.2017; 19(10): 1298.     CrossRef
  • Systemic therapy for recurrent meningioma
    E. Le Rhun, S. Taillibert, M. C. Chamberlain
    Expert Review of Neurotherapeutics.2016; 16(8): 889.     CrossRef
  • Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis
    Dorothee Cäcilia Spille, Katharina Heß, Cristina Sauerland, Nader Sanai, Walter Stummer, Werner Paulus, Benjamin Brokinkel
    World Neurosurgery.2016; 93: 346.     CrossRef
Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
Hae Woon Baek, Min Jee Park, Ye-Young Rhee, Kyoung Bun Lee, Min A Kim, In Ae Park
J Pathol Transl Med. 2015;49(1):52-60.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.26
  • 8,218 View
  • 72 Download
  • 26 Citations
AbstractAbstract PDF
Background
Endoscopic ultrasound–guided fine needle aspiration cytology (EUS-FNAC) is currently the most commonly used procedure for obtaining cytologic specimens of the pancreas. It is accurate, minimally invasive, safe and cost-effective. However, there is discrepancy between cytological and surgical diagnoses. This study was aimed at evaluating the diagnostic accuracy of EUS-FNAC of the pancreas. Methods: We performed a retrospective review of 191 cases of pancreatic lesions initially diagnosed by EUS-FNAC with subsequent histological diagnosis between 2010 and 2012 in the Department of Pathology, Seoul National University Hospital. Cytologic and surgical diagnoses were categorized into five groups: negative, benign, atypical, malignant, and insufficient for diagnosis. Subsequently, 167 cases with satisfactory yield in both surgical and cytology specimens were statistically analyzed to determine correlations with diagnosis. Results: In comparison to surgical diagnoses, cytologic diagnoses were true-positive in 103 cases (61.7%), true-negative in 28 cases (16.8%), false-positive in 9 cases (5.4%), and false-negative in 27 cases (16.1%). The diagnostic accuracy was 78.4%, sensitivity was 79.2%, and specificity was 75.7%. The positive predictive value was 92.0%, and negative predictive value was 50.9%. Conclusions: EUS-FNAC has high accuracy, sensitivity, specificity and positive predictive value. Overcoming the limitations of EUS-FNAC will make it a useful and reliable diagnostic tool for accurate evaluation of pancreatic lesions.

Citations

Citations to this article as recorded by  
  • Comparison of Endoscopic Ultrasound-Guided Fine-Needle Aspiration with Fine-Needle Biopsy for Solid Gastrointestinal Lesions: A Randomized Crossover Single-Center study
    Shivaraj Afzalpurkar, Vijay Kumar Rai, Nikhil Sonthalia, Gajanan Rodge, Awanesh Tewary, Mahesh Goenka
    Journal of Digestive Endoscopy.2023;[Epub]     CrossRef
  • The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks?
    Jin-Seok Park, Jae Hoon Lee, Tae Jun Song, Joune Seup Lee, Seok Jung Jo, Dong Wook Oh, Ki Byung Song, Dae Wook Hwang, Do Hyun Park, Sang Soo Lee, Song Cheol Kim, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim
    Surgical Endoscopy.2022; 36(5): 3192.     CrossRef
  • Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study
    Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao
    Journal of Magnetic Resonance Imaging.2022; 55(3): 823.     CrossRef
  • Role of Pathologist in the Era of Image-Guided and EUS-Guided Aspirations: A 10-Year Study at a Single Tertiary Care Oncology Institute in North India
    Gurudutt Gupta, Anila Sharma, Meenakshi Kamboj, Anurag Sharma, Sunil Pasricha, Garima Durga, Anurag Mehta, Avinash Rao
    Acta Cytologica.2022; 66(3): 187.     CrossRef
  • Predicting Factors for Pancreatic Malignancy with Computed Tomography and Endoscopic Ultrasonography in Chronic Pancreatitis
    Jian-Han Lai, Keng-Han Lee, Chen-Wang Chang, Ming-Jen Chen, Ching-Chung Lin
    Diagnostics.2022; 12(4): 1004.     CrossRef
  • Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study
    Wei Zhang, Ling Wang, Dan Li, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Qing Dong, Erkang Wang, Yuling Wang
    Analytical Methods.2022; 14(23): 2255.     CrossRef
  • Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment
    Wei Zhang, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Dingbin Liu, Yuling Wang
    Journal of Nanobiotechnology.2022;[Epub]     CrossRef
  • Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
    Maroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, Youssef Bouferraa, Morgan Bou Zerdan, Sabine Allam, Merima Ramovic, Stephen Graziano
    Cancers.2022; 14(19): 4589.     CrossRef
  • Molecular Subtyping and Precision Medicine for Pancreatic Cancer
    Fieke Froeling, Raffaella Casolino, Antonio Pea, Andrew Biankin, David Chang
    Journal of Clinical Medicine.2021; 10(1): 149.     CrossRef
  • Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
    R. Casolino, C. Braconi, G. Malleo, S. Paiella, C. Bassi, M. Milella, S.B. Dreyer, F.E.M. Froeling, D.K. Chang, A.V. Biankin, T. Golan
    Annals of Oncology.2021; 32(2): 183.     CrossRef
  • Diagnostic value of various liquid biopsy methods for pancreatic cancer
    Yuzhou Zhu, Hao Zhang, Nan Chen, Jianqi Hao, Hongyu Jin, Xuelei Ma
    Medicine.2020; 99(3): e18581.     CrossRef
  • Factors affecting cytological results of endoscopic ultrasound guided-fine needle aspiration during learning
    Jian-Han Lai, Hsiang-Hung Lin, Ching-Chung Lin
    Diagnostic Pathology.2020;[Epub]     CrossRef
  • Comparison between Conventional Smear and Liquid-Based Preparation in Endoscopic Ultrasonography-Fine Needle Aspiration Cytology of Pancreatic Lesions
    Soo Hee Ko, Jung-Soo Pyo, Byoung Kwan Son, Hyo Young Lee, Il Whan Oh, Kwang Hyun Chung
    Diagnostics.2020; 10(5): 293.     CrossRef
  • Evaluation of Pancreatic Lesions With Endoscopic Ultrasound and Fine Needle Aspiration
    Yan Luk, Wong Hoi She, Felix Che Lok Chow, Ka Wing Ma, Simon Hing Yin Tsang, Wing Chiu Dai, Tan To Cheung, Chung Mau Lo
    Surgical Innovation.2020; 27(5): 431.     CrossRef
  • The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound‐guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single
    Mrinmay Kumar Mallik, Laila Rafiq Qadan, Abdullah Al Naseer, Ali AlAli, Taiba Al Ansari, Shafi Ahmed Inamdar Naquib, Dilip Kumar Das, Kusum Kapila
    Cytopathology.2020; 31(6): 564.     CrossRef
  • Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
    Marta Toledano-Fonseca, M. Teresa Cano, Elizabeth Inga, Rosa Rodríguez-Alonso, M. Auxiliadora Gómez-España, Silvia Guil-Luna, Rafael Mena-Osuna, Juan R. de la Haba-Rodríguez, Antonio Rodríguez-Ariza, Enrique Aranda
    Cancers.2020; 12(7): 1754.     CrossRef
  • Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology
    Raza S. Hoda, Elizabeth B. Finer, Ronald N. Arpin, Matthew Rosenbaum, Martha B. Pitman
    Journal of the American Society of Cytopathology.2019; 8(3): 120.     CrossRef
  • Endoscopic ultrasound guided fine‐needle aspiration vs core needle biopsy for solid pancreatic lesions: Comparison of diagnostic accuracy and procedural efficiency
    Aslam Syed, Olivia Babich, Bharat Rao, Shailendra Singh, Neil Carleton, Abhishek Gulati, Archana Kulkarni, Mrinal Garg, Katie Farah, Gursimran Kochhar, Suzanne Morrissey, Marcia Mitre, Abhijit Kulkarni, Manish Dhawan, Jan F. Silverman, Majed Pharaon, Shya
    Diagnostic Cytopathology.2019; 47(11): 1138.     CrossRef
  • Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
    Claudio Luchini, Nicola Veronese, Alessia Nottegar, Vera Cappelletti, Maria G. Daidone, Lee Smith, Christopher Parris, Lodewijk A. A. Brosens, Maria G. Caruso, Liang Cheng, Christopher L. Wolfgang, Laura D. Wood, Michele Milella, Roberto Salvia, Aldo Scar
    Cancers.2019; 11(8): 1152.     CrossRef
  • It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer
    Jong-chan Lee, Haeryoung Kim, Hyoung Woo Kim, Jongchan Lee, Kyu-hyun Paik, Jingu Kang, Jin-Hyeok Hwang, Jaihwan Kim
    Hepatobiliary & Pancreatic Diseases International.2018; 17(6): 553.     CrossRef
  • Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer
    Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park
    Gastrointestinal Endoscopy.2018; 88(6): 926.     CrossRef
  • Cytological characteristics of atypical cells in endoscopic ultrasound-guided fine-needle aspiration specimens obtained from the pancreas
    Shikine ESAKA, Yoko MATSUDA, Yuri HAMASHIMA, Masayuki IMAIZUMI, Hiroya KOJIMA, Yuri KISO, Hiroto SHIRAHATA, Mayumi KINOSHITA, Akemi SUZUKI, Tomio ARAI
    The Journal of the Japanese Society of Clinical Cytology.2018; 57(4): 199.     CrossRef
  • Performance measures for endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
    Dirk Domagk, Kofi W Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan,
    United European Gastroenterology Journal.2018; 6(10): 1448.     CrossRef
  • Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
    Dirk Domagk, Kofi W. Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan
    Endoscopy.2018; 50(11): 1116.     CrossRef
  • Imaging modalities for characterising focal pancreatic lesions
    Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy
    Cochrane Database of Systematic Reviews.2017;[Epub]     CrossRef
  • Percutaneous ultrasound-guided core needle biopsy of solid pancreatic masses: Results in 250 patients
    Guven Kahriman, Nevzat Ozcan, Serap Dogan, Soner Ozmen, Kemal Deniz
    Journal of Clinical Ultrasound.2016; 44(8): 470.     CrossRef
Brief Case Reports
Mixed Carcinoid-Mucinous Adenocarcinoma Arising in Mature Teratoma of Mesentery
Su-Jin Shin, Eun-Mi Son, Chang Ohk Sung, Kyu-Rae Kim
J Pathol Transl Med. 2015;49(1):61-65.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.09.17
  • 9,377 View
  • 79 Download
  • 3 Citations
PDF

Citations

Citations to this article as recorded by  
  • Mixed neuroendocrine/Non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma
    Sandhyarani Dasaraju, Khalid Amin, Molly E. Klein, Colleen Rivard, Jordan Mattson, Sarah Davidson, Mahmoud A. Khalifa
    Gynecologic Oncology Reports.2022; 44: 101099.     CrossRef
  • A Case of Mature Cystic Teratoma of the Mesentery
    Ryogo Ito, Motoi Yoshihara, Atsuki Arimoto, Taro Aoba, Yoshihisa Shibata, Kazuhiro Hiramatsu, Takehito Kato
    The Japanese Journal of Gastroenterological Surgery.2021; 54(5): 344.     CrossRef
  • Primary ovarian mixed strumal and mucinous carcinoid arising in an ovarian mature cystic teratoma
    Na Rae Kim, Seung Yeon Ha, Jin Woo Shin, Soyi Lim, Chan Yong Park, Hyun Yee Cho
    Journal of Obstetrics and Gynaecology Research.2016; 42(2): 211.     CrossRef
Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of the Uterine Corpus
Eung-Seok Lee, Won Hwangbo, Insun Kim
J Pathol Transl Med. 2015;49(1):66-70.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.14
  • 9,751 View
  • 75 Download
  • 4 Citations
PDF

Citations

Citations to this article as recorded by  
  • Primary uterine Ewing sarcoma – A case report
    Yen-Chen Wu, Yu-Chien Kao, Ching-Wen Chang
    Taiwanese Journal of Obstetrics and Gynecology.2021; 60(1): 142.     CrossRef
  • Adjuvant chemotherapy for a primitive neuroectodermal tumor of the uterine corpus: A case report and literature review
    Munetoshi Akazawa, Toshiaki Saito, Kazuya Ariyoshi, Masao Okadome, Ryohei Yokoyama, Kenichi Taguchi
    Journal of Obstetrics and Gynaecology Research.2018;[Epub]     CrossRef
  • Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region
    Chang Gok Woo, Bora Lee, Joon Seon Song, Kyung-Ja Cho
    Applied Immunohistochemistry & Molecular Morphology.2018; 26(9): 632.     CrossRef
  • Primitive neuroectodermal tumor of uterus with synchronous in situ squamous cell carcinoma of cervix–A rare tumor with unusual association
    Ramneet Kaur, Shashi Dhawan, Prem Chopra, Sunita Bhalla
    Current Medicine Research and Practice.2017; 7(3): 109.     CrossRef
Placental Mesenchymal Dysplasia with Fetal Gastroschisis
Binnari Kim, Jiyeon Hyeon, Minju Lee, Hyewon Hwang, Yooju Shin, Suk-Joo Choi, Jung-Sun Kim
J Pathol Transl Med. 2015;49(1):71-74.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.12.14
  • 9,798 View
  • 81 Download
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • Diagnostic Accuracy of the Partograph Alert and Action Lines to Predict Adverse Birth Outcomes: A Systematic Review
    M. Bonet, O. T. Oladapo, J. P. Souza, A. M. Gülmezoglu
    Obstetrical & Gynecological Survey.2020; 75(5): 269.     CrossRef
  • Placental Mesenchymal Dysplasia
    Linda M. Ernst
    Journal of Fetal Medicine.2015; 2(3): 127.     CrossRef
A Rare Case of Mixed Type A Thymoma and Micronodular Thymoma with Lymphoid Stroma
Yoon Jin Cha, Joungho Han, Jimin Kim, Kyung Soo Lee, Young Mog Shim
J Pathol Transl Med. 2015;49(1):75-77.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.27
  • 9,146 View
  • 79 Download
  • 9 Citations
PDF

Citations

Citations to this article as recorded by  
  • Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas
    Min-Shu Hsieh, Hua-Lin Kao, Wen-Chang Huang, Shu-Ying Wang, Shin-Ying Lin, Ping-Yuan Chu, Chin-Chen Pan, Teh-Ying Chou, Hsiang-Ling Ho, Yi-Chen Yeh
    Modern Pathology.2023; 36(2): 100008.     CrossRef
  • Comparative clinicopathological and immunohistochemical study of micronodular thymoma and micronodular thymic carcinoma with lymphoid stroma
    Ping Ping Liu, Yun Chao Su, Yun Niu, Yan Fen Shi, Jie Luo, Ding Rong Zhong
    Journal of Clinical Pathology.2022; 75(10): 702.     CrossRef
  • GTF2Imutation in micronodular thymoma with lymphoid stroma
    Andrea Bille, Katherine Fryer, Andrew Wallace, Daisuke Nonaka
    Journal of Clinical Pathology.2022; : jcp-2022-208655.     CrossRef
  • Micronodular Thymoma With Lymphoid Stroma: A Trio of Cases, With Diverse-associated Histological Features
    Neha Bakshi, Shashi Dhawan, Seema Rao, Kishan Singh Rawat
    International Journal of Surgical Pathology.2021; 29(6): 693.     CrossRef
  • A case of thymoma with type A and micronodular thymoma with lymphoid stroma elements
    Clayton E. Kibler, Matthew J. Cecchini, Marie-Christine Aubry, Said F. Yassin, Julie K. Harrington
    Human Pathology: Case Reports.2021; 23: 200487.     CrossRef
  • Micronodular thymoma with lymphoid stroma: a clinicopathological study of five cases
    Katherine R. Hulme, Annabelle Mahar, Christopher Cao, Brian McCaughan, Wendy A. Cooper
    Pathology.2021; 53(7): 930.     CrossRef
  • Mixed Type A Thymoma and Micronodular Thymoma With Lymphoid Stroma
    Renqing Wang, Ling Nie
    International Journal of Surgical Pathology.2018; 26(4): 336.     CrossRef
  • Cystic Micronodular Thymoma. Report of a Case
    Mlika M
    Journal of Clinical, Medical and Experimental Images.2017; 1(1): 001.     CrossRef
  • Two Invasive Thymomas Incidentally Found during Coronary Artery Bypass Graft Surgery
    Navid Omidifar, Maral Mokhtari, Mansoureh Shokripour
    Case Reports in Pathology.2016; 2016: 1.     CrossRef
A Rare Case of Tumor-to-Tumor Metastasis of Thyroid Papillary Carcinoma within a Pulmonary Adenocarcinoma
Taebum Lee, Yoon Jin Cha, Sangjeong Ahn, Joungho Han, Young Mog Shim
J Pathol Transl Med. 2015;49(1):78-80.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.12.15
  • 7,622 View
  • 54 Download
  • 8 Citations
PDF

Citations

Citations to this article as recorded by  
  • Benign Neurofibroma/Schwannoma Hybrid Peripheral Nerve Sheath Tumor of the Ulnar Nerve Harboring a Metastatic Papillary Thyroid Carcinoma Deposit: A Case Report of Tumor-to-Tumor Metastasis
    Juan M. Colazo, Alexander N. Perez, Anthony D. Judice, Julia Quirion, Carlos N. Prieto-Granada, Ginger E. Holt, Samir Sami Amr
    Case Reports in Pathology.2022; 2022: 1.     CrossRef
  • A case of colorectal cancer with intratumoral metastasis to primary lung cancer
    Yasushi Cho, Mitsuhito Kaji, Shunsuke Nomura, Yusuke Motohashi, Masaaki Sato, Motoya Takeuchi
    The Journal of the Japanese Association for Chest Surgery.2021; 35(5): 576.     CrossRef
  • Tumor-to-tumor metastasis: metastatic invasive lobular carcinoma of the breast within adenocarcinoma of the lung
    Myoung Jae Kang, Ae Ri An, Myoung Ja Chung, Kyoung Min Kim
    Journal of Pathology and Translational Medicine.2020; 54(2): 188.     CrossRef
  • Metastatic Renal Cell Neoplasm Within a Papillary Thyroid Carcinoma as Incidental Finding in an Asymptomatic Patient: a Case Report
    Maria-Rosa Bella-Cueto, Mireia Pascua-Solé, Albert Cano-Palomares, M. Àngels Cabezuelo-Hernandez, Maria-Rosa Escoda-Giralt, Santiago Barcons-Vilaplana, Paula Serret-Miralles, Carmen Caral-Vanaclocha, Xavier Guirao-Garriga, Joan Prats-Lopez, Meritxell Meda
    SN Comprehensive Clinical Medicine.2020; 2(7): 978.     CrossRef
  • Squamous cell carcinoma of the lung and pulmonary metastasis of papillary thyroid carcinoma: a case report
    Arya Aminorroaya, Mohsen Khoshniatnikoo, Hossein Farrokhpour, Jamshid Vafaeimanesh, Mohammad Bagherzadeh
    Journal of Medical Case Reports.2019;[Epub]     CrossRef
  • Prostatic adenocarcinoma (PCa) metastasizing to renal cell carcinoma (RCC) with periureteral tumor deposit: A case of tumor-to-tumor metastasis (TTM)
    Jenissa Amor Dionisio Arceño, Jonathan Salcedo Mendoza, Josefino Cortez Castillo, Jeffrey Santos So
    Human Pathology: Case Reports.2017; 8: 27.     CrossRef
  • Dual malignancy in a thyroid; papillary thyroid carcinoma and small lymphocytic lymphoma; a report of a case with a cyto-histologic correlation
    Omar I. Ahmed, Ziyan T. Salih
    Diagnostic Cytopathology.2017; 45(9): 851.     CrossRef
  • Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy
    Yuqin Ma, Xia Zhang, Yutao Wang
    Oncology Letters.2017;[Epub]     CrossRef
Alveolar Rhabdomyosarcoma of the Lip in an Adult with Clear Cell Features
Jae Yeon Seok, Juhyeon Jeong, Young Woo Cheon, Hyun Yee Cho, Seung Yeon Ha, Dong Hae Chung
J Pathol Transl Med. 2015;49(1):81-84.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.06.03
  • 10,430 View
  • 73 Download
PDF
Squamous Cell Carcinoma of the Seminal Vesicle from Zinner Syndrome: A Case Report and Review of Literature
Younghoon Kim, Hae Woon Baek, Eunoh Choi, Kyung Chul Moon
J Pathol Transl Med. 2015;49(1):85-88.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.28
  • 9,446 View
  • 67 Download
  • 6 Citations
PDF

Citations

Citations to this article as recorded by  
  • Zinner syndrome: a rare diagnosis in infancy
    Joanne Michelle Oida Rose, Ravi Banthia, Zain Tamboli, Hira Lal
    BMJ Case Reports.2022; 15(5): e248558.     CrossRef
  • Classifying seminal vesicle cysts in the diagnosis and treatment of Zinner syndrome: A report of six cases and review of available literature
    Zhengwu Tan, Bing Li, Lan Zhang, Ping Han, Haitao Huang, Andrew Taylor, Xin Li
    Andrologia.2020;[Epub]     CrossRef
  • Incidental imaging findings suggesting Zinner syndrome in a young patient with pulmonary embolism: A case report
    Benedikt Hergan, Franz A. Fellner, Kaveh Akbari
    Radiology Case Reports.2020; 15(4): 437.     CrossRef
  • Ectopic ureter associated with Zinner’s syndrome in a kidney recipient: case report and literature review
    Korhan Tuncer, Gizem Kilinc, Ismail Sert, Goksever Akpinar, Cem Tugmen
    Revista da Associação Médica Brasileira.2020; 66(5): 692.     CrossRef
  • Zinner’s Syndrome: A Rare Diagnosis of Dysuria Based on Imaging
    Ahmed Ibrahimi, Abdelmoughit Hosni, Idriss Ziani, Fatima Zahra Laamrani, Hachem El Sayegh, Laila Jroundi, Lounis Benslimane, Yassine Nouini, Apul Goel
    Case Reports in Urology.2020; 2020: 1.     CrossRef
  • Primary squamous cell carcinoma of the seminal vesicle
    Lu Fang, Qian Hong, Lei Chen, Yi Wang, Liang-Kuan Bi, Dong-Dong Xie, De-Xin Yu
    Medicine.2019; 98(12): e14788.     CrossRef

JPTM : Journal of Pathology and Translational Medicine